Pages that link to "Q33728239"

The following pages link to Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models (Q33728239):

Displaying 43 items.

• Splice Variants of Androgen Receptor and Prostate Cancer (Q26740592) (← links)
• Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression (Q28257270) (← links)
• Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members (Q28646036) (← links)
• Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer (Q30276399) (← links)
• AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancer (Q30544584) (← links)
• Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET (Q30643770) (← links)
• Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines (Q33988757) (← links)
• Recent developments in antiandrogens and selective androgen receptor modulators (Q34195295) (← links)
• Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups (Q34542337) (← links)
• Management of prostate cancer in port harcourt, Nigeria: changing patterns (Q34555654) (← links)
• MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand (Q35238452) (← links)
• MK591, a second generation leukotriene biosynthesis inhibitor, prevents invasion and induces apoptosis in the bone-invading C4-2B human prostate cancer cells: implications for the treatment of castration-resistant, bone-metastatic prostate cancer (Q35431448) (← links)
• A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer (Q35465076) (← links)
• A Transductionally Retargeted Adenoviral Vector for Virotherapy of Her2/neu-Expressing Prostate Cancer (Q35678429) (← links)
• Castration-resistant prostate cancer: mechanisms, targets, and treatment. (Q35864027) (← links)
• AMBRA1 and SQSTM1 expression pattern in prostate cancer (Q36149486) (← links)
• Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth (Q36635865) (← links)
• Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3. (Q36682155) (← links)
• Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches (Q37537958) (← links)
• Cancer and the metastatic substrate (Q37573461) (← links)
• Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches. (Q38184622) (← links)
• Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges. (Q38413737) (← links)
• Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells (Q38734062) (← links)
• Dose-Dependent Therapeutic Distinction between Active and Passive Targeting Revealed Using Transferrin-Coated PGMA Nanoparticles. (Q38815759) (← links)
• DNA Methylation and the HOXC6 Paradox in Prostate Cancer (Q42585509) (← links)
• A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers. (Q47825566) (← links)
• Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression (Q47941645) (← links)
• The Addition of Manganese Porphyrins during Radiation Inhibits Prostate Cancer Growth and Simultaneously Protects Normal Prostate Tissue from Radiation Damage (Q49184042) (← links)
• Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model. (Q49587940) (← links)
• Ambra1 induces autophagy and desensitizes human prostate cancer cells to cisplatin. (Q50174651) (← links)
• Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer (Q50420907) (← links)
• Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF-β signaling. (Q52623463) (← links)
• PC-346C (Q54938432) (← links)
• PC346DCC (Q54938576) (← links)
• PC346Flu1 (Q54938578) (← links)
• PC346Flu2 (Q54938579) (← links)
• Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer (Q57475174) (← links)
• Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy? (Q57817247) (← links)
• Recent trends in the management of advanced prostate cancer (Q57821875) (← links)
• Knockdown of FOXP1 promotes the development of lung adenocarcinoma (Q58577353) (← links)
• CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo (Q64377962) (← links)
• Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells. (Q64987877) (← links)
• Targeting Wnt/EZH2/microRNA-708 signaling pathway inhibits neuroendocrine differentiation in prostate cancer (Q90470428) (← links)